Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
Иммуномодулирующая роль внеклеточного матрикса в микроокружении при заболеваниях печени
2020-11-11
SCID: 54.1/vhbsuaq5
Discuss with AI
ECM-DAMPsdecellularized ECM scaffoldsextracellular matriximmune modulationliver fibrosis
Figures from the paper
Abstract (AI)
Chronic liver disease when accompanied by underlying fibrosis, is characterised by an accumulation of extracellular matrix (ECM) proteins and chronic inflammation. Although traditionally considered as a passive and largely architectural structure, the ECM is now being recognised as a source of potent DAMPs with immune-active peptides and domains. In parallel, the ECM anchors a range of cytokines, chemokines and growth factors, all of which are capable of modulating the immune responses. A growing body of evidence shows that ECM proteins themselves are capable of interacting both directly, via a wide range of receptors including integrins and TLRs, and indirectly with immune cells. ECM deposition and remodelling during fibrosis can result in release or formation of ECM-DAMPs, which can drive immune cellular infiltration and sterile inflammation. Both the ECM and immune response are interlinked and integral in driving fibrosis, although their precise interactions in the context of chronic liver disease are poorly understood. This review aims to shed light on the ECM-immune interactions underlying liver disease, in particular fibrosis of different aetiologies, by describing the main ECM intact proteins and ECM-DAMPs with known immune regulatory activity. We also discuss how tissue engineering could provide new opportunities to explore ECM-immune cell interactions in bioreactor-based dynamic 3D models containing intact decellularized ECM scaffolds. A better understanding of these interactions would aid in the identification of new antifibrotic and immunomodulatory targets for treatment and biomarkers in liver disease.
Key Findings
1
Dynamic three-dimensional bioreactor models using intact decellularized ECM scaffolds could help investigate ECM–immune interactions and identify antifibrotic or immunomodulatory targets and biomarkers.
2
ECM proteins can directly interact with immune cells through receptors including integrins and Toll-like receptors, while also indirectly modulating immunity by binding cytokines, chemokines, and growth factors.
3
Fibrosis-associated ECM deposition and remodelling generate or release ECM-derived damage-associated molecular patterns that promote immune-cell infiltration and sterile inflammation.
4
Fibrotic chronic liver disease involves extracellular matrix accumulation and persistent inflammation, with the ECM acting as an active immunoregulatory component rather than merely an architectural scaffold.
5
Reciprocal interactions between the ECM and immune responses contribute to fibrosis across different liver disease aetiologies, but their precise mechanisms remain poorly understood.
Research Object
Extracellular matrix within the chronic liver disease microenvironment, particularly fibrotic liver tissue
Research Subject
Immunomodulatory interactions and mechanisms of ECM deposition, remodelling, and ECM-DAMP activity in liver fibrosis
Publication Details
Publication Date
2020-11-11
Journal
Publisher
ISSN
Cited by
148
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest